بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

/ بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

بسنت فرج عبده متولي الشوريمي

الموقع الشخصى

بسنت فرج عبده متولي الشوريمي

الكلية العلوم - القسم الكيمياء

الدرجات العلمية

بكالوريوس فى الكيمياء, -جامعة الزقازيق [2018]
ماجستير فى الكيمياء, -جامعة الزقازيق [2022]
(تحضير مشتقات اليوراسيل المندمجة ودراسة خواصها البيولوجية)
دكتوراه فى الكيمياء, -جامعة الزقازيق [2024]
(تحضير ودراسة الخواص البيولوجية لبعض مركبات البيريميدين الجديدة)

الحالة الوظيفية الحالية :

قائم بالعمل

التدرج الوظيفى الأكاديمى

معيد : 9/4/2020
مدرس مساعد : 29/6/2022
مدرس : 31/12/2024

الأبحاث العلمية

1 - Synthesis and in vitro study of pyrimidine–phthalimide hybrids as VEGFR2 inhibitors with antiproliferative activity (1444).

2 - Synthesis and molecular docking of some novel 3-thiazolyl-coumarins as inhibitors of VEGFR-2 kinase (1444).

3 - Mechanochemical synthesis and molecular docking studies of new azines bearing indole as anticancer agents (1444).

4 - Green synthesis and molecular docking study of some new thiazoles using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst (1445).

5 - Green route synthesis and molecular docking of azines using cellulose sulfuric acid under microwave irradiation (1444).

6 - Synthesis, molecular docking study, and biological evaluation and of new thiadiazole and thiazole derivatives incorporating isoindoline-1,3-dione moiety as anticancer and antimicrobial agents (1445).

7 - Green Biocatalyst for Ultrasound-Assisted Thiazole Derivatives: Synthesis, Antibacterial Evaluation, and Docking Analysis (1445).

8 - Cyanauric Chloride as a key precursor and a core component for Three-Armed Triazolopyrimidines: Recent finding about SARs and docking analyses (1445).

9 - Chitosan–sulfonic acid-catalyzed green synthesis of naphthalene-based azines as potential anticancer agents (1445).

10 - Synthesis, molecular docking, in silico study, and evaluation of bis-thiazole-based curcumin derivatives as potential antimicrobial agents (1445).

11 - Design and synthesis of novel hybrids incorporating thiadiazole or thiazole-naphthalene: Anticancer assessment and molecular docking study (1445).

12 - Design, synthesis and antitumor activity of novel pyran-functionalized uracil derivatives: docking studies (1444).

13 - Green synthesis of hydrazono-thiazolones using vitamin B1 and their antibacterial implications (1446).

14 - Efficient Green Synthesis of Hydrazide Derivatives Using L-Proline: Structural Characterization, Anticancer Activity, and Molecular Docking Studies (1446).

15 - Facile one-pot synthesis and in silico study of new heterocyclic scaffolds with 4-pyridyl moiety: Mechanistic insights and X-ray crystallographic elucidation (1445).

16 - Synthesis of novel Bis-1, 2, 4-Triazolo [3, 4-b][1, 3, 4] Thiadiazines from natural camphoric acid as potential anti-candidal agents (1445).

17 - Synthesis of Bis-thiazoles Tethered 1,4-Dihydropyridine and Pyridine Linkers via Simple Oxidation and their Molecular Docking as VEGFR -TK Inhibitors (1445).

18 - Novel phthalimide-pyrimidine hybrids as potent anti-tubercular agents (1445).

19 - Corrigendum to “Synthesis, molecular docking study, and biological evaluation and of new thiadiazole and thiazole derivatives incorporating isoindoline-1, 3-dione moiety as … (1446).

20 - Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents (1446).

21 - Novel thiazolyl-pyrimidine derivatives as potential anticancer agents: Synthesis, biological evaluation, and molecular docking studies (1446).

22 - Synthesis, Molecular Docking and Anticancer Activity of Some 5-Aryl-5,10-dihydropyrido[2,3-d:6,5-d′]dipyrimidine-2,4,6,8-tetraone Derivatives and Pyrido[2,3-d]pyrimidines (1443).

23 - Synthesis, characterization, and in silico studies of substituted 2,3-dihydro-1,3,4-thiadiazole derivatives (1446).

24 - Synthesis of Bis-Pyrimidothiazine and Bis-Pyrimidothiadiazinone derivatives as VEGFR2/KDR inhibitors via Michael and Mannich reactions (1446).

25 - Biological evaluation and molecular docking studies of novel aza-acyclic nucleosides as putative antimicrobial, anticancer, and antioxidant agents (1447).

26 - Using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst (1445).

27 - Synthesis, Anticancer Evaluation, and Molecular Docking of Novel Thiazolobenzimidazole–Thiazole Hybrids as Potent Colon Cancer Inhibitors (1447).

28 - Antiplatelet therapy through inhibition of P2Y12 and phosphodiesterase receptors by novel synthesis 1,3-dicyclohexylpyrimidine-2,4(1H,3H)-dione derivatives with computational evaluation (1447).

29 - Design and Evaluation of Novel Benzimidazolo-Triazole-Tetrazole Derivatives as Anticancer Agents Against MCF-7 Cells (1447).

30 - Novel pyrimidinone scaffolds synthesized via nanotechnology as promising inhibitors of the hepatitis A virus with computational analyses (1447).

31 - Benzimidazotriazines as adenosine receptor-targeting anticancer agents: Synthesis, cytotoxicity, DFT, and docking studies (1447).

32 - Design, Synthesis, Cytotoxicity Assessment, and Molecular Docking of Novel Triazolopyrimidines as Potent Cyclin-Dependent Kinase 4 Inhibitors (1447).

33 - Synthesis of Pyrido[2,3-d]Azolopyrimidinones: Design and Epidermal Growth Factor Receptor-Targeted Molecular Docking Toward Novel Anticancer Leads (1447).

34 - Design, Synthesis, and Biological Assessment of Bis-thiazole Derivatives as Promising Anticancer Agents with Molecular Docking Insights (1446).

35 - A Novel Series of Benzimidazole-Triazole-Tetrazole Compounds: Synthesis, Structural Analysis, and Cytotoxic Activity Against MCF-7 Cells (1446).

36 - Innovative Pivaloyl Fixed 1,3-Thiazole-2-imines as Multitarget Inhibitors: Synthesis, Enzyme Inhibition, Molecular Docking and Structure Activity Relationship (SAR) Studies (1446).

المجالات البحثية